Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

Delayed Quote. Delayed BATS EUROPE - 08/28 05:19:59 pm
94.3000 CHF   -0.05%
08/28 NOVARTIS : continues commitment to go the last mile in effort to eli..
08/27DJFDA Approves Amgen's Cholesterol-Lowering Drug Repatha -- Update
08/27DJFDA Approves Amgen's Cholesterol Drug
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on NOVARTIS AG
08/04 VIKING THERAPEUTICS : Ligand Reports Second Quarter 2015 Financial Results
08/04 ALLERGAN : Akorn Inc's Hi-Tech Pharmacal infringes Allergan glaucoma drug patent..
08/03 NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
08/03 CSL completes Novartis influenza vaccine business acquisition
08/03 Analysis - New cocktails to test limits of cancer drug pricing
08/02 NOVARTIS : completes divestiture of influenza vaccines business to CSL Limited f..
07/31 Diageo announces changes to its Board of Directors
07/31 NOVARTIS : $76,645 Federal Contract Awarded to Alcon Laboratories
07/31 NOVARTIS : Alcon Research Assigned Patent
07/31 CSL : Update on Novartis influenza vaccines acquisition
07/30DJAmgen Raises 2015 Outlook, Results Beat Expectations -- 2nd Update
07/30DJAmgen Raises 2015 Outlook, Results Beat Expectations
07/30 Teva's MS drug Copaxone has strong second-quarter sales
07/30 NOVARTIS : Mereo BioPharma Acquires Clinical Assets from Novartis
07/29 IGNYTA : Boosts Leadership Capacity with Appointment of Bernard Parker as Chief ..
07/29 NOVARTIS : Forma Therapeutics Appoints John Hohneker, M.D., as Executive Vice Pr..
07/29 GLAXOSMITHKLINE : GSK shares rise after earnings beat estimates
07/29 2ND UPDATE : GlaxoSmithKline On Track For 2015 And Confident For 2016
07/29 GSK flags up pipeline as HIV drugs help it beat profit forecasts
07/29 GSK flags up pipeline as HIV drugs help it beat profit forecasts
07/29 UPDATE : GlaxoSmithKline On Track For 2015, Confident In 2016 Outlook
07/29 NOVARTIS : European drugmaker GSK sees slide in profit after it swapped some ass..
07/29DJGSK Boosted by New Vaccines
07/29 GlaxoSmithKline On Track For Guidance, Confident In 2016 Outlook
07/29DJNovartis Spins Off Three Pipeline Drugs Into New Company
07/29 NOVARTIS : partners with Phase 4 Partners and institutional investors to help cr..
07/28DJMerck Earnings Hurt by Arthritis Drug Knockoffs
07/28DJMerck Earnings Hurt by Arthritis Drug Knockoffs
07/27 NOVARTIS : Health and Human Services Department (HHS); Food and Drug Administrat..
07/27 NOVARTIS : FDA approves Novartis drug Odomzo (sonidegib) for locally advanced ba..
07/27 NOVARTIS : Foundation confirms new members of its Board of trustees, including n..
07/27 NOVARTIS : Foundation confirms new members of its Board of trustees, including n..
07/25DJTeva in Talks to Buy Allergan's Generics Unit -- 4th Update
07/25 NOVARTIS : WHO prequalifies improved malaria treatment
07/25 NOVARTIS : Clinical Ink Updates on CentrosHealth Platform
07/24 Allergan said to be exploring split into two businesses - source
07/24 NOVARTIS : FDA approves Odomzo from Novartis for increasingly common skin cancer..
07/24DJBiogen Shares Plunge 22% After Outlook Slashed -- Update
07/24 NOVARTIS : FDA OK's Odomzo from Novartis for common skin cancer type
07/24DJBiogen Shares Plunge 17.2% After It Slashes Outlook
07/24 MORPHOSYS : Announces Clinical Milestone in Blood Disorders Program
07/24 NOVARTIS : FDA approves Novartis drug Odomzo® (sonidegib) for locally advanced b..
07/24 NOVARTIS : Sandoz Launches Breathe Africa Program to Improve Asthma Diagnosis, T..
07/24 NOVARTIS : drug Revolade® recommended by CHMP for EU approval to treat patients ..
07/24 NOVARTIS : combination therapy Tafinlar® and Mekinist® achieves important EU and..
07/24 NOVARTIS : Alcon Research Assigned Patent
07/24DJBiogen Shares Plunge 22%, Outlook Slashed
07/23 NOVARTIS : Genmab Announces Submission of Supplemental Biologics License Applica..
07/23DJLilly's Sales Inch Higher as Drug Maker Boosts 2015 Outlook -- 2nd Update
07/23 GLAXOSMITHKLINE : Dr James Shannon appointed to Immodulon Therapeutics Board of ..
07/23DJLilly Results Lifted By Higher Volumes, Animal Health--Update
07/23DJLilly's Top, Bottom Lines Exceed
07/23 NOVARTIS INDIA : NET PROFIT FALLS 6% TO Rs13.45 CRORE
07/23 NOVARTIS : Clinical Ink Updates on CentrosHealth Platform
07/23 NOVARTIS : Building the knowledge base of 300-strong team
07/22 NOVARTIS : Patent Issued for IOL with Varying Correction of Chromatic Aberration
07/22 AEQUUS PHARMACEUTICALS : Announces It Has Entered Into a Definitive Agreement to..
07/22 NOVARTIS : Researchers Submit Patent Application, "New Inhibitors for Treating D..
07/22DJADRs End Lower; National Bank of Greece, Petrobras Trade Actively
07/22 NOVARTIS : Special Notice - J-- 740-16-1-2153-0006_Alcon Ophthalmic Surgical Equ..
07/22 NOVARTIS : quarterly report dashes hopes of better outlook for 2015
07/22 IGNYTA : Boosts Leadership Capacity with Appointment of Bernard Parker as Chief ..
07/21 Apple adds to stocks' slump; dollar slips
07/21 Apple adds to stocks' slump; dollar slips
07/21 NOVARTIS : Building the knowledge base of 300-strong team
07/21DJADRs End Mixed; Infosys Rises
07/21 NOVARTIS : Court ruling clears way for Novartis launch of first low-cost biotech..
07/21 AMGEN : Court ruling clears way for Novartis' low-cost biotech drug
07/21DJNovartis Can Sell Copycat of Amgen's Neupogen in September, Court Rules
07/21DJEuropean Shares Fall, Ending Nine-Session Rally -- 4th Update
07/21DJEuropean Shares Slip After Greek Rally -- 3rd Update
07/21 NOVARTIS : $163,110 Federal Contract Awarded to Alcon Laboratories
07/21DJEUROPE MARKETS : European Stocks Fall Back After Greek-fueled Run Of Wins
07/21 NOVARTIS : Strong US dollar hurts Q2 profits of Switzerland's Novartis
07/21 NOVARTIS : Strong US dollar hurts Swiss pharmaceutical company Novartis with 32-..
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Income Statement Evolution
More Financials